TY - JOUR
T1 - Characterization of the rhipicephalus (Boophilus) microplus sialotranscriptome profile in response to theileria equi infection
AU - Paulino, Patrícia
AU - Vitari, Gabriela
AU - Rezende, Antonio
AU - Couto, Joana
AU - Antunes, Sandra
AU - Domingos, Ana
AU - Peckle, Maristela
AU - Massard, Carlos
AU - Araújo, Flávio
AU - Santos, Huarrisson
N1 - Funding Information:
Funding: The authors disclose receipt of the following financial support for the research, authorship, or publication of this paper. The National Council for Scientific and Technological Development and the ’Carlos Chagas Filho’ Foundation for Research Support of the State of Rio de Janeiro provided financial support for this study.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/2
Y1 - 2021/2
N2 - This study intends to characterize the sialotranscriptome profile of Rhipicephalus (Boophilus) microplus in response to Theileria equi and identify genes of interest with differential genomic ex-pression, indicating relevant targets in the tick–protozoan interactions. The experimental design consisted of RNA sequencing from uninfected and T. equi-infected R. microplus salivary glands (SGs) to obtain transcriptomic profiles for characterization and comparison. A total of 288,952 transcripts were obtained from both tick profiles, 3456 transcripts (p < 0.05) differentially expressed in response to T. equi infection. The uninfected SGs’ registered 231,179 transcripts, of which 155,359 were annotated. The most transcribed sequences were female-specific histamine binding protein and lipocalins. Regarding the T. equi-infected SGs, from the 238,964 assembled transcripts, 163,564 were annotated. The most transcribed sequences were histone demethylase JARID1 and Y-box-binding protein. Five transcripts (cystatin, arginase, nuclear factor κB kinase inhibitor subunit β (IκB), IκB delta, lysosomal-trafficking regulator, and reeler protein) presented the gene ontology (GO) category “response to protozoan” and were exclusively displayed in the T. equi-infected profile. The tran-scriptome of T. equi was also analyzed, registering 4728 hits. The study’s genetic and molecular information would be of great value for future studies and biotechnological applications envisaging disease control.
AB - This study intends to characterize the sialotranscriptome profile of Rhipicephalus (Boophilus) microplus in response to Theileria equi and identify genes of interest with differential genomic ex-pression, indicating relevant targets in the tick–protozoan interactions. The experimental design consisted of RNA sequencing from uninfected and T. equi-infected R. microplus salivary glands (SGs) to obtain transcriptomic profiles for characterization and comparison. A total of 288,952 transcripts were obtained from both tick profiles, 3456 transcripts (p < 0.05) differentially expressed in response to T. equi infection. The uninfected SGs’ registered 231,179 transcripts, of which 155,359 were annotated. The most transcribed sequences were female-specific histamine binding protein and lipocalins. Regarding the T. equi-infected SGs, from the 238,964 assembled transcripts, 163,564 were annotated. The most transcribed sequences were histone demethylase JARID1 and Y-box-binding protein. Five transcripts (cystatin, arginase, nuclear factor κB kinase inhibitor subunit β (IκB), IκB delta, lysosomal-trafficking regulator, and reeler protein) presented the gene ontology (GO) category “response to protozoan” and were exclusively displayed in the T. equi-infected profile. The tran-scriptome of T. equi was also analyzed, registering 4728 hits. The study’s genetic and molecular information would be of great value for future studies and biotechnological applications envisaging disease control.
KW - Equine piroplasmosis
KW - RNA-seq
KW - Tick defense
KW - Tick-protozoan interactions
UR - http://www.scopus.com/inward/record.url?scp=85100546187&partnerID=8YFLogxK
U2 - 10.3390/pathogens10020167
DO - 10.3390/pathogens10020167
M3 - Article
AN - SCOPUS:85100546187
SN - 2076-0817
VL - 10
SP - 1
EP - 18
JO - Pathogens
JF - Pathogens
IS - 2
M1 - 167
ER -